The stockmarket melt-up just keeps going
Despite all the bad news, markets just keep hitting new highs. Should you be worried?
Levels of public debt not seen since World War II; a labour shortage; fast-rising inflation; more new Covid-19 variants; small businesses suffering from supply crunches; chaos in Afghanistan; rising mutterings about inequality; anti-wealth and anti-market policies in China; ridiculously high equity valuations in the US. It’s a lot for markets to cope with. You’d think they’d wobble some, but no. Instead, the melt-up just keeps going – and America’s S&P 500 index just keeps hitting record highs. Should you worry?
There are stories you can tell to make yourself feel a bit better (stockmarkets are nothing more than a sum of stories). You could perhaps argue that US earnings estimates are rising so fast that it makes everything look kind of OK. S&P 500 stocks as a whole beat analysts’ estimates nicely in both the first and second quarters – so everyone is now busy upgrading their forecasts for the year. The higher these go (S&P average forecast operating earnings per share are now at a record high) the less awful valuations look, and the easier it is to justify endlessly rising stockmarkets.
You could also argue that the Federal Reserve, America's central bank, is clearly very conscious of the stockmarket (maybe too conscious) and will be keeping interest rates so low for so long that if you want an income of any kind, there is no alternative to the stockmarket. You might also note that companies must be feeling pretty optimistic: stock issuance is currently at its highest level ever in the US – “blowing away the last high set in the run up to the Tech Bubble”, say the analysts at asset manager GMO. And this isn’t just about new firms coming to market (the Spacs – special purpose acquisition companies – you have heard so much about). Instead, most new issuance is coming from “seasoned companies”.
Subscribe to MoneyWeek
Subscribe to MoneyWeek today and get your first six magazine issues absolutely FREE
Sign up to Money Morning
Don't miss the latest investment and personal finances news, market analysis, plus money-saving tips with our free twice-daily newsletter
Don't miss the latest investment and personal finances news, market analysis, plus money-saving tips with our free twice-daily newsletter
Unfortunately, none of these things are quite enough. Analysts have a trying tendency to extrapolate everything – basing forecasts not on actual predictions of the future, but on assumptions that the future will be almost identical to the immediate past. Yardeni Research notes that the average analyst’s estimate of forward earnings for US energy companies is up by 1,558% since last year’s lockdown lows. In lockdown, analysts assumed lockdown forever. Out of lockdown they perhaps assume pent-up demand release forever. The latter is as unlikely now as the former was then. As for issuance, it would be nice to think that it reflected companies being full of brilliant ideas as to productive ways to use the cash. However, it is just as likely, as GMO says, to reflect that “Wall Street knows an eager, price-insensitive buyer when it sees one... when the ducks are quacking, it’s time to feed ’em”.
And interest rates? It makes some sense to think about markets in relative terms, but at some point absolutes will matter too. When that happens, eager, price-insensitive buyers will be in for a shock. With that in mind, let us bore you again with the suggestion that you bring some of your cash home – to the UK market. The UK is not as cheap as it was, but it is much cheaper than most other markets. If we don’t buy it, private-equity firms will soon own the lot. And we won’t like that.
Sign up to Money Morning
Our team, led by award winning editors, is dedicated to delivering you the top news, analysis, and guides to help you manage your money, grow your investments and build wealth.
Merryn Somerset Webb started her career in Tokyo at public broadcaster NHK before becoming a Japanese equity broker at what was then Warburgs. She went on to work at SBC and UBS without moving from her desk in Kamiyacho (it was the age of mergers).
After five years in Japan she returned to work in the UK at Paribas. This soon became BNP Paribas. Again, no desk move was required. On leaving the City, Merryn helped The Week magazine with its City pages before becoming the launch editor of MoneyWeek in 2000 and taking on columns first in the Sunday Times and then in 2009 in the Financial Times
Twenty years on, MoneyWeek is the best-selling financial magazine in the UK. Merryn was its Editor in Chief until 2022. She is now a senior columnist at Bloomberg and host of the Merryn Talks Money podcast - but still writes for Moneyweek monthly.
Merryn is also is a non executive director of two investment trusts – BlackRock Throgmorton, and the Murray Income Investment Trust.
-
Water bills set to rise by 21% a year – how to cut costs
Households could see their water bills soar by roughly 21% annually, but suppliers warn it’s not enough to address essential repairs.
By Oojal Dhanjal Published
-
Should you invest in Canada?
Canada presents a compelling opportunity for investors who want to look beyond the US. Greg Eckel of Canadian General Investments highlights four favourites
By Greg Eckel Published
-
What will a broken-up Google look like?
The US courts have ruled that Google is a monopoly, leaving it facing the prospect of a break-up. WIll that be a good thing?
By Matthew Lynn Published
-
How will the UK gambling sector be hit by the Budget?
There are concerns for the UK gambling sector in the lead-up to the Autumn Budget. What could be on the cards?
By Dr Matthew Partridge Published
-
HSBC returns to cost-cutting plan
HSBC is set to revamp its commercial banking division – but will it come at a cost?
By Dr Matthew Partridge Published
-
Is Brevan Howard Macro a good investment?
Holding Brevan Howard, a world-leading vehicle through an investment trust, offers diversification on the cheap
By Rupert Hargreaves Published
-
How can China boost consumption?
China's new policies may give consumption a cyclical boost, even if long-term gains require more serious reforms
By Cris Sholto Heaton Published
-
Pfizer shares rise as US investor takes $1 billion stake
Pfizer shares are on the up since US activist investor Starboard Value built up a stake in the drug maker. But strategic options appear limited
By Dr Matthew Partridge Published
-
What is the outlook for oil prices?
Oil prices will be set by the face-off between Saudi Arabia and US shale producers. Could tail risks change the possible outcome?
By Cris Sholto Heaton Published
-
A fairer deal for investment trusts
New rules on how investment trusts report costs should ditch the idea that investors only need to look at one number
By Cris Sholto Heaton Published